Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410534 | SCV000486468 | likely pathogenic | GRACILE syndrome | 2016-06-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001218287 | SCV001390162 | pathogenic | not provided | 2021-08-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser82*) in the BCS1L gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with BCS1L-related conditions. ClinVar contains an entry for this variant (Variation ID: 371015). Loss-of-function variants in BCS1L are known to be pathogenic (PMID: 17314340, 25895478). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001334242 | SCV001527034 | pathogenic | Mitochondrial complex III deficiency nuclear type 1 | 2018-04-10 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |